Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

Clinical trial NCT05321602 · COMPLETED

Trial details

NCT number: NCT05321602
Sponsor: Luye Pharma Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Psychotic Disorders Mood Disorders Schizophrenia Spectrum and Other Psychotic Disorders Mental Disorders Antipsychotic Agents Tranquilizing Agents Central Nervous System Depression Physiological Effects of Drugs Psychotropic Drugs Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action

Start date: 2021-09-08
Primary completion: 2022-09-23
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.